Sofinnova Investments, Inc. Neurocrine Biosciences Inc Transaction History

Sofinnova Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $17.5 Million - $20.1 Million	-203,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $18.2 Million - $20.8 Million	203,200 New	203,200 $19.8 Million
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $16.6 Million - $22.7 Million	-191,679 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $3 Million - $3.64 Million	35,819 Added 22.98%	191,679 $17.3 Million
Q2 2019 Aug 13, 2019	BUY	$72.24 - $91.27 $3.14 Million - $3.97 Million	43,454 Added 38.66%	155,860 $13.2 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $3.53 Million - $4.66 Million	50,906 Added 82.77%	112,406 $9.9 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $4.2 Million - $7.65 Million	61,500 New	61,500 $4.39 Million

634

93.9M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.4B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.